| J2777 | Injection, faricimab‑svoa, 0.1 mg | 20,460 | $30 | $593.3K |
| J0178 | Injection, aflibercept, 1 mg | 220 | $690 | $155.5K |
| J3490 | Unclassified drugs | 50 | $1,820 | $91.1K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 720 | $120 | $86.4K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 970 | $90 | $82.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 740 | $60 | $46.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 500 | $90 | $44.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,450 | $30 | $43.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 220 | $120 | $26.7K |
| J9035 | Injection, bevacizumab, 10 mg | 360 | $60 | $19.9K |